Zolan Kanno-Youngs, a White House correspondent for The New York Times, dives into the Biden administration's major shift on marijuana policy. He discusses the potential reclassification of marijuana from Schedule I to Schedule 3 and its far-reaching implications for legal, medical, and business sectors. Kanno-Youngs also examines the timing of these changes, particularly in relation to the upcoming presidential election, and explores the evolution of Biden's drug policies amidst growing public support for reform.
The Biden administration recommended moving marijuana from Schedule One to Schedule Three, acknowledging its potential medical benefits and reflecting changing public sentiment towards its use.
The reclassification of marijuana could reduce federal sentences for related crimes, facilitate research on its benefits, and remove limitations for business owners in the industry.
Deep dives
Biden Administration Recommends Loosening Federal Restrictions on Marijuana
The Biden administration has recommended loosening federal restrictions on marijuana by moving it from Schedule One to Schedule Three classification. This shift acknowledges potential medical benefits of marijuana and reflects changing public sentiment towards its use. The change aims to provide leniency in legal approaches to marijuana, potentially reducing federal sentences for related crimes.
Impact of Marijuana's Schedule One Classification on Society
The classification of marijuana as a Schedule One drug has resulted in increased arrests and convictions, impacting individuals even post-release due to criminal records. This classification has hindered research on marijuana's benefits and restricted medical officials from studying its uses. Additionally, business owners in the marijuana industry have faced limitations due to federal classification, affecting tax credits and financial access.
Biden's Approach: Incremental Progress in Criminal Justice Reform
President Biden's decision to reclassify marijuana aligns with his incremental approach to criminal justice reform. While signaling a shift in perception, the change emphasizes slow institutional progress and a cautious stance towards significant policy shifts. Biden's historical stance on drug policy reform indicates a methodical process, aiming to navigate changes while respecting existing legal systems and societal views.
For half a century, the federal government has treated marijuana as one of the more dangerous drugs in the United States. On Tuesday, the Biden administration signaled a significant shift in approach.
Zolan Kanno-Youngs, a White House correspondent for The Times, explains how big an impact the proposed changes could have.
Guest: Zolan Kanno-Youngs, a White House correspondent for The New York Times.
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode